Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diastolic Dysfunction, Symptomatic Heart Failure”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Post-approval studies (Phase 4)Study completedNCT00171106
What this trial is testing

Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure

Who this might be right for
Diastolic Dysfunction, Symptomatic Heart Failure
Novartis 150
Large-scale testing (Phase 3)Study completedNCT00775840
What this trial is testing

Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.

Who this might be right for
Heart Failure
Takeda 22
Not applicableEnrolling By InvitationNCT07057323
What this trial is testing

Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure

Who this might be right for
Heart Failure Preserved Ejection Fraction
Mayo Clinic 35
Testing effectiveness (Phase 2)Looking for participantsNCT06705023
What this trial is testing

Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.

Who this might be right for
Myocardial InjuryLV DysfunctionCoronary Artery Disease+1 more
Ralf Rothoerl 36
Large-scale testing (Phase 3)Ended earlyNCT02291237
What this trial is testing

Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
Gilead Sciences 172